Trusted Resource for Clinical Trials, Protocols & Progress
Multi-factor authentication (MFA) adds an additional layer of login security by requiring more than just a username and password. In clinical trials, where systems like EDC, CTMS, IRT, and eTMF manage sensitive patient and protocol data, implementing MFA is critical to:
Click to read the full article.
In traditional clinical trial environments, each system (EDC, eTMF, CTMS, IRT, etc.) has its own login. This siloed access approach leads to:
Click to read the full article.
In clinical trials, staff offboarding is not just an HR matter—it is a critical compliance and data integrity concern. Failure to promptly revoke system access for departing personnel can result in:
Click to read the full article.
In GxP-regulated clinical research, access to electronic systems must be controlled and monitored to prevent data manipulation, unauthorized disclosure, and protocol violations. Traditional periodic audits or post-event log reviews are no longer sufficient.
Click to read the full article.
In blinded or double-blinded clinical trials, maintaining the integrity of the blinding is crucial to ensure scientific validity. Any unauthorized access to treatment allocation, unblinded safety data, or randomization information can compromise the trial outcomes and lead to regulatory repercussions.
Click to read the full article.
As clinical trials expand globally and adopt decentralized models, managing user access dynamically becomes critical. Unlike static permissions configured at study startup, dynamic access provisioning allows for:
Click to read the full article.
The principle of Least Privilege (PoLP) mandates that users should only have the minimum access rights necessary to perform their assigned tasks. In the context of clinical trials, this applies to platforms such as:
Click to read the full article.
In clinical research, every interaction with trial data must be traceable. Whether it’s entering patient data, reviewing a protocol amendment, or exporting a dataset, these actions must be logged securely. This is where access logs become critical—they are not just technical records but regulatory evidence.
Click to read the full article.
Electronic Data Capture (EDC) and electronic Trial Master File (eTMF) platforms are the backbone of digital clinical trials. Both require tightly controlled user permissions to ensure data integrity, confidentiality, and traceability. Misconfigured access can result in audit findings, data breaches, or protocol deviations.
Click to read the full article.
Electronic Data Capture (EDC) and electronic Trial Master File (eTMF) platforms are the backbone of digital clinical trials. Both require tightly controlled user permissions to ensure data integrity, confidentiality, and traceability. Misconfigured access can result in audit findings, data breaches, or protocol deviations.
Click to read the full article.
